Goldman Sachs analyst Chris Shibutani lowered the price target on BioNTech (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View Analyst PT Change

Pfizer (PFE) Asks FDA to Amend EUA and Include Booster for Everyone 18+, Analyst Sees Good Chances for Winning Approval and Upgrades BioNTech (BNTX) to BuyNovember 11, 2021 9:01 AM Form 6-K BioNTech SE For: Nov 09November 10, 2021 6:03 AM Pfizer seeks FDA nod for COVID vaccine boosters for U.S. adultsNovember 9, 2021 2:58 PM Pfizer (PFE), BioNTech (BNTX) request to amend FDA EUA for booster dose of COVID-19 vaccine to include all individuals 18 years of age and olderNovember 9, 2021 2:47 PM Pfizer (PFE), BioNTech (BNTX) Are Expected Wednesday to Ask Regulators to Expand Authorization of Coronavirus Booster Shots to Include All Adults - NYTNovember 9, 2021 10:52 AM Form 6-K BioNTech SE For: Nov 05November 9, 2021 8:15 AM Form 6-K BioNTech SE For: Nov 05November 9, 2021 6:53 AM BioNTech sees up to 17 billion eur in vaccine revenue this yearNovember 9, 2021 6:47 AM BioNTech SE (BNTX) Reports Q3 EPS of EUR12.35November 9, 2021 6:47 AM BioNTech Announces Third Quarter 2021 Financial Results and Corporate UpdateNovember 9, 2021 6:45 AM